Menu
Recruiting NCT07224958

ROAM OA: Functional and Patient Reported Outcomes Wearing a Knee Brace for Unicompartmental OA

No phase Interventional Knee Osteoarthritis

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: ROAM OA Single Upright Knee Brace, Ossur Unloader One Knee Brace or Standard of Care.
Who it may be relevant to
Registry conditions: Knee Osteoarthritis. Basic parameters: 40 years — 85 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

The aim of this study is to conduct a comparative evaluation of the ROAM OA Single Upright Brace and the Ossur Unloader One Knee Brace in subjects with medial compartment osteoarthritis. The focus is on comparing the immediate and short-term biomechanical effects of these braces on knee adduction moments and spatiotemporal gait parameters, as well as assessing the long-term efficacy of the ROAM OA brace in improving pain and functional outcomes for individuals with osteoarthritis.

Detailed description

INTRODUCTION The Enovis ROAM OA outcomes study is a prospective, single-center, crossover study with a subsequent randomized control phase and extended follow-up gait analysis, intended to evaluate the efficacy of the ROAM OA knee brace in subjects with medial knee osteoarthritis (OA).

The purpose of this study is to conduct a comparative evaluation of the ROAM OA Single Upright Brace and the Ossur Unloader One Knee Brace in subjects with medial compartment OA. The focus is on comparing the immediate and short-term biomechanical effects of these braces on knee adduction moments and spatiotemporal gait parameters, as well as assessing the long-term efficacy of the ROAM OA brace in improving pain and functional outcomes for individuals with OA.

1.1 Background Osteoarthritis of the knee significantly impacts the quality of life and functional capacity of those affected. Globally, hundreds of millions of people live with OA, with the knee being the most frequently affected joint. This condition leads to symptoms such as pain, swelling, and stiffness, which impair mobility and daily activities, affecting overall well-being and social connectedness.

The prevalence of knee OA is influenced by factors such as aging and obesity, and with an aging population, the incidence of knee OA is expected to rise. This increase underscores the need for effective management strategies.

Non-invasive interventions such as knee orthoses have been highlighted in OA management. These devices, including the ROAM OA Single Upright Brace, are designed to unload the affected compartment of the knee to reduce pain and improve function. Despite their potential benefits, the efficacy and biomechanical impacts of these braces require further investigation to optimize their clinical use.

Assessment of health-related quality of life (HRQoL) in patients with knee OA helps quantify disease burden and treatment effectiveness. Instruments such as the Knee Injury and Osteoarthritis Outcome Score (KOOS) and the Visual Analog Pain Scale (VAS) are commonly used to evaluate impairment and pain, respectively.

As the prevalence of knee OA continues to increase, there is a clear need for ongoing research into effective management strategies, including orthotic interventions. Understanding the impact of these approaches on quality of life and functional outcomes is essential to guide clinical decision-making.

1.2 Rationale Although several studies have examined knee braces in OA, there remains limited understanding of their specific biomechanical effects and correlation with patient-reported outcomes. The influence of braces on knee adduction moments-a key factor in medial compartment loading and pain-remains insufficiently characterized.

This study is designed to address that gap by integrating objective gait analysis with patient-reported outcomes. Assessing changes in knee adduction moments and other gait parameters will provide insight into the mechanical effectiveness of the ROAM OA Single Upright Brace. Evaluating patient-reported outcomes such as pain, comfort, and function will clarify how mechanical improvements correspond to perceived clinical benefit.

1.3 Device Description The ROAM OA knee brace, manufactured by Enovis, is intended for individuals with symptoms, physical findings, or radiographic evidence of moderate to severe unicompartmental knee OA, postoperative meniscal repair where unicompartmental unloading is indicated, or varus-valgus conditions that may benefit from compartmental unloading.

It is a single-patient-use device that alleviates pain due to single-compartment OA by applying controlled forces to the leg to shift load from the affected knee compartment to the healthier one.

1.4 Clinical Data to Date This is the first clinical study to collect prospective data on the ROAM OA knee brace.

STUDY DESIGN 2.1 Number of Study Sites Subjects will be recruited from Midwest Orthopedics at Rush and all affiliated clinical locations. All study activities will be conducted in the Rush Department of Orthopedic Surgery Motion Analysis Laboratory.

2.2 Number of Subjects Thirty subjects will be enrolled.

2.3 Estimated Study Duration Enrollment is expected at a rate of approximately two subjects per month, with clinical follow-up at four and eight weeks. The total study duration is estimated at 18 months.

STUDY OBJECTIVES 3.1 Primary Objective Biomechanical Comparison: To compare the immediate and short-term biomechanical effects of the ROAM OA brace and the Ossur Unloader One brace, focusing on knee adduction moments and spatiotemporal gait parameters.

Long-term Efficacy: To evaluate the long-term effectiveness of the ROAM OA brace in improving pain and functional outcomes among individuals with knee OA.

3.2 Secondary Objectives Evaluate safety and comfort of the ROAM OA brace, including any adverse effects and user experience.

Assess changes in gait parameters over time to determine the brace's role in promoting functional mobility and reducing medial knee load.

STUDY ENDPOINTS 4.1 Primary Endpoints Changes in Knee Adduction Moment: Measured at baseline (no brace), immediately after fitting each brace, and at four- and eight-week follow-ups using markerless gait analysis.

VAS Pain Changes: Pain levels assessed via VAS at each study milestone, including baseline, post-fitting, and follow-ups.

4.2 Secondary Endpoints Brace comfort and user compliance

Pain medication usage

KOOS score changes

Device-related and serious adverse event rate

Changes in spatiotemporal gait parameters (step length, walking speed, cadence)

STUDY POPULATION 5.1 Eligibility Criteria Inclusion Criteria

Adults aged 40-85 years

BMI \<35

Diagnosed with medial compartment knee OA

Walking pain ≥4 on the VAS

Willingness to wear the assigned brace daily and complete study follow-up

Ability to walk independently for at least 20 minutes

Stable use of over-the-counter pain medications

No intra-articular injections within three months of enrollment

Exclusion Criteria

Lateral or patellofemoral OA

Previous knee joint replacement

Ligamentous instability or acute lower extremity injury

Neurological disorders affecting gait

Interventions

  • Device ROAM OA Single Upright Knee Brace
    A commercially available single-upright knee brace designed to offload the medial compartment of the knee in patients with unicompartmental osteoarthritis; manufactured by Enovis. Participants will wear the brace daily for the duration of the study.
  • Device Ossur Unloader One Knee Brace or Standard of Care
    Participants will receive the Ossur Unloader One knee brace or no brace (standard of care) and will follow standard management and physical therapy guidelines. This group serves as the active comparator to the ROAM OA brace.

Primary outcome measures

  • Change in knee adduction moment during gait [Time frame: Baseline, 4 weeks, and 8 weeks]
  • Change in Visual Analog Scale (VAS) walking pain [Time frame: Baseline, 4 weeks, and 8 weeks]
Secondary outcome measures (2)
  • Change in KOOS (Knee injury and Osteoarthritis Outcome Score) subscale scores [Time frame: Baseline, 4 weeks, and 8 weeks]
  • Change in knee range of motion (ROM) [Time frame: Baseline, 4 weeks, and 8 weeks]

Eligibility criteria

Inclusion criteria

  • Inclusion Criteria:
  • Age 40-85 years.
  • BMI ≤ 35.
  • Physician-diagnosed medial compartment knee osteoarthritis.
  • Visual Analog Scale (VAS) walking pain ≥ 4.
  • Willing to wear assigned brace ≥ 4 hours/day.
  • Able to walk independently for 20 minutes unaided.
  • Stable pain medication regimen ≥ 4 weeks.
  • ≥3 months since last hyaluronic acid (HA), platelet-rich plasma (PRP), or steroid injection.

Exclusion criteria

  • Lateral or patellofemoral osteoarthritis.
  • Prior knee replacement.
  • Significant ligament injury or acute lower limb injury.
  • Neurological condition affecting gait.
  • Severe psychiatric or neurological disorder affecting pain perception.
  • Skin condition or allergy preventing brace use.
  • Current use of another brace or assistive device.
  • Recent opioid or corticosteroid use (<4 weeks).
  • Pregnant.

Exclusion criteria

\-

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Crossover
Masking
Open label
Primary purpose
Treatment

Study locations

United States · 1 center
  • Rush University Medical Center — Chicago

Publications

  • Hochberg MC, Altman RD, April KT, Benkhalti M, Guyatt G, McGowan J, Towheed T, Welch V, Wells G, Tugwell P; American College of Rheumatology. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken). 2012 Apr;64(4):465-74. doi: 10.1002/acr.21596. PMID 22563589
  • Chang J, Yuan Y, Fu M, Wang D. Health-related quality of life among patients with knee osteoarthritis in Guangzhou, China: a multicenter cross-sectional study. Health Qual Life Outcomes. 2023 May 27;21(1):50. doi: 10.1186/s12955-023-02133-x. PMID 37244981

Identifiers

NCT: NCT07224958 · 23110204-IRB01

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗